Stroke Prevention in Subclinical Atrial Fibrillation
N Engl J Med
.
2024 Apr 18;390(15):1441.
doi: 10.1056/NEJMc2401632.
Authors
Todd C Lee
1
,
Sanjay Kaul
2
,
John Mandrola
3
Affiliations
1
McGill University, Montreal, QC, Canada todd.lee@mcgill.ca.
2
Cedars-Sinai Medical Center, Los Angeles, CA.
3
Baptist Health Louisville, Louisville, KY.
PMID:
38631011
DOI:
10.1056/NEJMc2401632
No abstract available
Publication types
Letter
Comment
MeSH terms
Atrial Fibrillation* / drug therapy
Humans
Pyrazoles / therapeutic use
Pyridones / therapeutic use
Stroke* / prevention & control
Substances
apixaban
Pyrazoles
Pyridones